Literature DB >> 3092195

The glucagon superfamily: precursor structure and gene organization.

G I Bell.   

Abstract

The glucagon superfamily includes the polypeptides glucagon, secretin, vasoactive inhibitory peptide (VIP), gastric inhibitory peptide and growth hormone-releasing factor (GHRF). Complementary DNA clones which encode the precursors to glucagon, VIP and GHRF have been isolated. Although the sizes and sequences of preproglucagon, prepro VIP and preproGHRF are distinct, the structural organization of the three precursors is similar. Each has a signal peptide, an NH2-terminal peptide and one, two or three peptides whose sequences are related to glucagon. Prepro VIP and preproGHRF also have a COOH-terminal peptide. The sequences of two different anglerfish preproglucagon molecules have been determined and they contain the sequences of glucagon and a related peptide. In contrast, hamster, cow and rat preproglucagon contain the sequences of glucagon and two related peptides. Human and rat prepro VIP contain the sequences of VIP and the related peptide PHM/PHI-27. Human and rat preproGHRF contain the sequence of only one peptide related to glucagon, i.e., GHRF. The genes for both preproglucagon and preproGHRF have been isolated. Their exon-intron organization indicates that each exon encodes a functionally distinct region of the precursor and mRNA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3092195     DOI: 10.1016/0196-9781(86)90160-9

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  14 in total

1.  The secretin gene: evolutionary history, alternative splicing, and developmental regulation.

Authors:  A S Kopin; M B Wheeler; J Nishitani; E W McBride; T M Chang; W Y Chey; A B Leiter
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 2.  Is Glucagon-like peptide-1, an agent treating diabetes, a new hope for Alzheimer's disease?

Authors:  Lin Li
Journal:  Neurosci Bull       Date:  2007-01       Impact factor: 5.203

Review 3.  A Plethora of GLP-1 Agonists: Decisions About What to Use and When.

Authors:  Susan L Samson; Alan J Garber
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

4.  Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells.

Authors:  Y Rouillé; G Westermark; S K Martin; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

Review 5.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

6.  Expression of mRNA for vasoactive intestinal peptide in normal human colon and during inflammation.

Authors:  A Schulte-Bockholt; J G Fink; D A Meier; M F Otterson; G L Telford; K Hopp; T R Koch
Journal:  Mol Cell Biochem       Date:  1995-01-12       Impact factor: 3.396

7.  Coexistence of pancreatic polypeptide (PP)-and glucagon-immunoreactivity in pancreatic endocrine cells of mouse.

Authors:  J H Rombout; M E Abad; F M Binkhorst; J J Taverne-Thiele
Journal:  Histochemistry       Date:  1987

8.  Glucose-dependent insulinotropic peptide: structure of the precursor and tissue-specific expression in rat.

Authors:  C C Tseng; L A Jarboe; S B Landau; E K Williams; M M Wolfe
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

Review 9.  VIP: molecular biology and neurobiological function.

Authors:  I Gozes; D E Brenneman
Journal:  Mol Neurobiol       Date:  1989       Impact factor: 5.590

10.  Sequence of an intestinal cDNA encoding human gastric inhibitory polypeptide precursor.

Authors:  J Takeda; Y Seino; K Tanaka; H Fukumoto; T Kayano; H Takahashi; T Mitani; M Kurono; T Suzuki; T Tobe
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.